Search

everythinglearnresearchcommunity

for

Search:↓

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Lifestyle changes, exercise, and antioxidants can help manage polycystic ovary syndrome.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Skin changes can reveal serious hormone-related diseases, helping save lives.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

Early neurosteroid changes can alter adult brain function and behavior.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Lifestyle changes improve weight, waist size, menstrual regularity, and acne in teens with PCOS.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Lifestyle changes improve symptoms and fertility in hyper-androgenic women.

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Testosterone raises blood pressure and changes kidney protein levels.

COVID-19 can cause hair loss and nail changes in some patients.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

Hypoxic training didn't change skin features, but skin barrier function is linked to blood lipid levels.

Certain drugs can change hair color, either lightening or darkening it.

A specific genetic change in the KRT71 gene causes a hair loss condition in Hereford cattle.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Inflammation and metabolic changes are linked to postpartum hair loss after a first C-section.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.